Jerimy C. Polf, PhD

• 1998: B.S., Applied Physics, Oklahoma State University
• 2000: M.S., Photonics, Oklahoma State University, Thesis Advisor – Stephen McKeever, Thesis Title: THE ROLE OF OXYGEN VACANCIES IN THERMOLUMINESCNECE PROCESSESS IN AL203:C
• 2002 PhD., Photonics, Oklahoma State University, Thesis Advisor – Stephen McKeever, Thesis Title: A STUDY OF OPTICALLY STIMULATED LUMINECENCE IN Al2O3 FIBERS FOR THE DEVELOPMENT OF A REAL-TIME, FIBER OPTIC DOSIMETRY SYSTEM

Post Graduate Education and Training

• 8/2002−2/2003 Postdoctoral Fellowship, Oklahoma State University, Stillwater, OK, Stephen McKeever, Ph.D., 8/2002−2/2003
• 2/2003−3/2005 Postdoctoral Fellowship, University of Texas, M. D. Anderson Cancer Center, Houston, TX, Wayne Newhauser, Ph.D., 2/2003−3/2005

Certificaitons

• 06/2008 Diplomate, American Board of Radiology

Dr. Polf is currently an Associate Professor at the Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore.  He is a faculty member in the department of Radiation Oncology at the Maryland Proton Treatment Center.  Dr. Polf did his graduate studies at Oklahoma State University where he received an IGERT fellowship from the National Science Foundation. He received his PhD in physics in 2002. After completing graduate school Dr. Polf did a post doctoral fellowship in Proton Beam Radiotherapy at the University of Texas MD Anderson Cancer center, and following its completion, joined the faculty at MD Anderson in 2005. Dr. Polf joined the University of Maryland, Baltimore faculty in 2013 where he has worked as a clinical medical physicist at the Maryland Proton Treatment Center.

Dr. Polf has published over 40 pier reviewed articles and book chapters and has been funded by the American Cancer Society and the National Cancer Institute for his research into prompt gamma imaging during Proton Beam Radiotherapy. Currently Dr. Polf and his research team is funded by an Academic Industrial Partnership R01 grant from the NIH focused on the development of a clinical prompt gamma imaging system capable of imaging the proton beam during treatment delivery as a means of verifying proper dose delivery to the patient. Additionally, Dr. Polf is actively studying the application of the new imaging technology developed for proton beam radiotherapy to other areas such as diagnostic imaging, theranostics, and radio-isotope monitoring/imaging for industrial and military applications.

Proton Therapy, Prompt Gamma Imaging

Polf JC, Peterson S, Ciangaru G, Gillin M, Beddar A. Prompt gamma-ray emission from biological tissues during proton irradiation: a preliminary study. Phys Med Biol 54(3):731-743, 2009.

Polf JC, Peterson SW, McCleskey M, Roeder BT, Spiridon A, Beddar S, Trache L. Measurement and calculation of characteristic prompt gamma ray spectra emitted during proton irradiation. Phys Med Biol 54(11):N519-N527, 11/2009.

Polf JC, Bronk L, Driessen W, Arap W, Pasqualini, R. Gillin, M., Enahnced Relative biological effectiveness of proton radiotherapy in tumor cells with internalized gold nanoparticles. Appl Phys Letters 98:193702(1-3), 2011.

Mackin D, Peterson SW, Beddar S, Polf JC, Evaluation of a stochastic reconstruction algorithm for use in Compton camera imaging and beam range verification from secondary gamma emission during proton therapy, Phys Med Biol 57:3537-3553, 2012.

McCleskey M, Kaye W, Mackin DS, Beddar S, He Z, Polf JC, Evaluation of a multistage CdZnTe Compton camera for prompt γ imaging for proton therapy, Nucl. Instrum. And Meth A, 785:163-169, 2015.

Polf JC, Avery S, Mackin D and Beddar S, Imaging of prompt gamma rays emitted during delivery of clinical proton beams with a Compton camera: feasibility studies for range verification, Phys. Med. Biol. 60:7085-7099, 2015.

Polf JC and Parodi K, In vivo range monitoring with secondary emission for ion beam radiotherapy, Physics Today, 68(10):28-33, 2015.